PILIANIDIS, G. et al. Can euglycemic diabetic ketoacidosis caused by SGLT2 inhibitors be avoided in COVID-19 and other acute infections? European Journal of Case Reports in Internal Medicine, v. 11, n. 3, 2 Feb.2024.